Traphagen Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-98,840	Closed	-$8.22M	–	169
2023 Q2	$8.22M	Buy	98,840 +1,684	+2%	+$141K	1.07%	18
2023 Q1	$7.41M	Buy	97,156 +1,012	+1%	+$84K	1.09%	16
2022 Q4	$7.98M	Buy	96,144 +784	+0.8%	+$63.5K	1.25%	16
2022 Q3	$7.56M	Sell	95,360 -67	-0.1%	-$5.65K	1.39%	17
2022 Q2	$7.09M	Buy	95,427 +7,444	+8%	+$559K	1.29%	18
2022 Q1	$7.91M	Sell	87,983 -19,253	-18%	-$1.78M	1.28%	17
2021 Q4	$6.32M	Sell	107,236 -28,975	-21%	-$3.49M	1.04%	16
2021 Q3	$8.3M	Buy	136,211 +115,739	+565%	+$14.9M	1.49%	14
2021 Q2	$1.37M	Buy	20,472 +8,179	+67%	+$1.08M	0.23%	36
2021 Q1	$832K	Buy	+12,293	New	+$1.84M	0.15%	57